Targeting Oral Cancer Andrew M. Fribley
Publisher: Springer International Publishing
Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells. Unlike traditional chemotherapy, targeted oral therapies are directed against changes or processes that take place in growing cancer cells. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA. Plasmonic imaging of human oral cancer cell communities during programmed cell death by nuclear-targeting silver nanoparticles. Oral delivery of Salmonella may, represent a potential strategy for the treatment of tumor. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways. Fribley graduated with a BS from Central Michigan University, Mt. Doi: 10.1111/j.1600-0714.2009.00759. Targeting oral cancer lesion in vivo with modularly designed magnetite nanoparticles on ResearchGate, the professional network for scientists. And invasion of oral squamous cell carcinoma by targeting Wnt-7b. Experimental study of antiangiogenic gene therapy targeting VEGF in oral cancer . Oral squamous cell carcinoma commonly known as oral cancer (OC) is the most common malignancy of head and neck with high global public health impact.